June 12, 2024 - SirnaMed has entered a strategic partnership with several global health organizations to develop RNA-based therapeutics for emerging viral threats. This collaboration aims to harness SirnaMed's cutting-edge RNA interference technology to create rapid response treatments for viral outbreaks.
"Emerging viruses pose a significant threat to global health, and rapid development of effective treatments is crucial," said CEO Dr. James Carter. "By partnering with leading health organizations, we can accelerate the development and deployment of these therapies."
The initiative will focus on viruses with pandemic potential, leveraging SirnaMed's expertise in RNA technology to provide a robust defense against future outbreaks.
Comments